Schedule 13D ownership disclosure

AURIS MED HLDG AG

Security class unavailable · CUSIP: H0381L104

Event date: 2018-07-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,869,083
Percent of class
24.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-18-008746
Form type
SC 13D/A
Filer
Altamira Therapeutics Ltd.
CIK
CIK 1601936
Filed
Jul 23, 2018
Reporting period
Jul 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub